These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 16422890)
61. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. Shabsigh R; Kaufman JM; Steidle C; Padma-Nathan H J Urol; 2004 Aug; 172(2):658-63. PubMed ID: 15247755 [TBL] [Abstract][Full Text] [Related]
62. Pharmacokinetics and relative bioavailability of absorbed testosterone after administration of a 1.62% testosterone gel to different application sites in men with hypogonadism. Miller J; Britto M; Fitzpatrick S; McWhirter C; Testino SA; Brennan JJ; Zumbrunnen TL Endocr Pract; 2011; 17(4):574-83. PubMed ID: 21454244 [TBL] [Abstract][Full Text] [Related]
63. Effect of testosterone supplementation on sexual function in hypogonadal men with erectile dysfunction. Mulhall JP; Valenzuela R; Aviv N; Parker M Urology; 2004 Feb; 63(2):348-52; discussion 352-3. PubMed ID: 14972487 [TBL] [Abstract][Full Text] [Related]
64. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study. Shifren JL; Davis SR; Moreau M; Waldbaum A; Bouchard C; DeRogatis L; Derzko C; Bearnson P; Kakos N; O'Neill S; Levine S; Wekselman K; Buch A; Rodenberg C; Kroll R Menopause; 2006; 13(5):770-9. PubMed ID: 16932240 [TBL] [Abstract][Full Text] [Related]
65. Testosterone gel shows promise in Phase III trial. AIDS Alert; 1999 Jun; 14(6):67. PubMed ID: 11366410 [TBL] [Abstract][Full Text] [Related]
66. Transdermal testosterone delivery: testosterone patch and gel. Gooren LJ; Bunck MC World J Urol; 2003 Nov; 21(5):316-9. PubMed ID: 14551721 [TBL] [Abstract][Full Text] [Related]
67. Spuriously elevated testosterone measurements caused by application of testosterone gel at or near the phlebotomy site. Kirk D; Misita C Ann Pharmacother; 2013 Jan; 47(1):e5. PubMed ID: 23324503 [TBL] [Abstract][Full Text] [Related]
68. Clinical experience using the Androderm testosterone transdermal system in hypogonadal adolescents and young men with beta-thalassemia major. De Sanctis V; Vullo C; Urso L; Rigolin F; Cavallini A; Caramelli K; Daugherty C; Mazer N J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():891-900. PubMed ID: 10091163 [TBL] [Abstract][Full Text] [Related]
69. Testosterone treatment comes of age: new options for hypogonadal men. Nieschlag E Clin Endocrinol (Oxf); 2006 Sep; 65(3):275-81. PubMed ID: 16918944 [TBL] [Abstract][Full Text] [Related]
70. Pharmacokinetics and drying time of testosterone 2% gel in men with hypogonadism: a multicenter, open-label, single-arm trial. Morgentaler A; McGettigan J; Xiang Q; Danoff TM; Gould EM Int J Impot Res; 2015; 27(2):41-5. PubMed ID: 25056809 [TBL] [Abstract][Full Text] [Related]
71. A pilot study of an investigational testosterone transdermal patch system in young women with spontaneous premature ovarian failure. Kalantaridou SN; Calis KA; Mazer NA; Godoy H; Nelson LM J Clin Endocrinol Metab; 2005 Dec; 90(12):6549-52. PubMed ID: 16174721 [TBL] [Abstract][Full Text] [Related]
72. Testosterone replacement therapy can increase circulating endothelial progenitor cell number in men with late onset hypogonadism. Liao CH; Wu YN; Lin FY; Tsai WK; Liu SP; Chiang HS Andrology; 2013 Jul; 1(4):563-9. PubMed ID: 23653307 [TBL] [Abstract][Full Text] [Related]
73. Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome. Giltay EJ; Tishova YA; Mskhalaya GJ; Gooren LJ; Saad F; Kalinchenko SY J Sex Med; 2010 Jul; 7(7):2572-82. PubMed ID: 20524974 [TBL] [Abstract][Full Text] [Related]
74. Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism. Merza Z; Blumsohn A; Mah PM; Meads DM; McKenna SP; Wylie K; Eastell R; Wu F; Ross RJ Int J Androl; 2006 Jun; 29(3):381-91. PubMed ID: 16390499 [TBL] [Abstract][Full Text] [Related]
75. Testosterone replacement therapy improves mood in hypogonadal men--a clinical research center study. Wang C; Alexander G; Berman N; Salehian B; Davidson T; McDonald V; Steiner B; Hull L; Callegari C; Swerdloff RS J Clin Endocrinol Metab; 1996 Oct; 81(10):3578-83. PubMed ID: 8855804 [TBL] [Abstract][Full Text] [Related]
76. A pilot study assessing the impact of heat on the transdermal delivery of testosterone. Shomaker TS; Zhang J; Ashburn MA J Clin Pharmacol; 2001 Jun; 41(6):677-82. PubMed ID: 11402637 [TBL] [Abstract][Full Text] [Related]
77. Application of synthetic membranes in establishing bio-predictive IVPT for testosterone transdermal gel. Mohamed LA; Kamal N; Elfakhri KH; Ibrahim S; Ashraf M; Zidan AS Int J Pharm; 2020 Aug; 586():119572. PubMed ID: 32599131 [TBL] [Abstract][Full Text] [Related]
78. Abnormal testosterone levels in partners of patients using testosterone gels. Spielberg TE J Sex Med; 2005 Mar; 2(2):278. PubMed ID: 16422898 [No Abstract] [Full Text] [Related]
79. Comparison of the skin irritation potential of two testosterone transdermal systems: an investigational system and a marketed product. Jordan WP; Atkinson LE; Lai C Clin Ther; 1998; 20(1):80-7. PubMed ID: 9522106 [TBL] [Abstract][Full Text] [Related]
80. Transdermal uptake of benzophenone-3 from clothing: comparison of human participant results to model predictions. Eftekhari A; Hill JT; Morrison GC J Expo Sci Environ Epidemiol; 2021 Feb; 31(1):149-157. PubMed ID: 33303958 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]